Patents by Inventor Imtiaz A. Chaudry

Imtiaz A. Chaudry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mometasone furoate for treating airway passage and lung diseases
    Publication number: 20020127187
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Application
    Filed: January 16, 2002
    Publication date: September 12, 2002
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of mometasone furoate for treating airway passage and lung diseases
    Publication number: 20020103175
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Application
    Filed: January 16, 2002
    Publication date: August 1, 2002
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Aerosol formulations of albuterol and 1,1,1,2-tetrafluoroethane
    Patent number: 6416743
    Abstract: Aerosol formulations substantially free of chlorofluorocarbons, for oral and/or nasal administration are described. The formulations comprise 1,1,1,2 tetrafluoroethane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment utilizing the formulations also are described.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: July 9, 2002
    Assignee: Schering Corporation
    Inventors: Julianne Fassberg, Joel A. Sequeira, Imtiaz A. Chaudry, Michael Kopcha
  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent number: 6365581
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: April 2, 2002
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Orally administrable solid ribavirin dosage forms and process for making them
    Patent number: 6337090
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin and a process for making such solid dosage forms are disclosed.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: January 8, 2002
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Orally administrable solid dosage form
    Patent number: 6335032
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: March 6, 2000
    Date of Patent: January 1, 2002
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Mometasone furoate suspensions for nebulization
    Patent number: 6187765
    Abstract: An aqueous nebulizer suspension contains water, mometasone furoate monohydrate, a nonionic surfactant, a soluble salt and optionally a pH buffer. The suspension may be prepared by ultrasonication or jet milling techniques.
    Type: Grant
    Filed: October 6, 1998
    Date of Patent: February 13, 2001
    Assignee: Schering Corporation
    Inventors: David Harris, Joel A. Sequeira, Imtiaz A. Chaudry
  • Stabilized antihistamine syrup
    Patent number: 6132758
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Grant
    Filed: June 1, 1998
    Date of Patent: October 17, 2000
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Chlorofluorocarbon-free mometasone furoate aerosol formulations
    Patent number: 6068832
    Abstract: The invention relates to suspension aerosol formulations which exhibit stable particle sizes, containing mometasone furoate, about 1 to about 10 weight percent ethanol and 1,1,1,2,3,3,3-Heptafluoropropane as the propellant. A surfactant, such as oleic acid, can also be included. These formulations are suitable for use in metered dose inhalers.
    Type: Grant
    Filed: August 27, 1997
    Date of Patent: May 30, 2000
    Assignee: Schering Corporation
    Inventors: Julianne Berry, Joel A. Sequeira, Imtiaz A. Chaudry
  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent number: 6057307
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: May 2, 2000
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Orally administrable solid dosage form
    Patent number: 6051252
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is subsantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: April 18, 2000
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Process of making solid ribavirin dosage forms
    Patent number: 5916594
    Abstract: A process of making an orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin as determined is disclosed.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: June 29, 1999
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Orally administrable solid dosage form
    Patent number: 5914128
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: June 22, 1999
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Use of mometasone furoate for treating lower airway passage and lung diseases
    Patent number: 5889015
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: August 14, 1997
    Date of Patent: March 30, 1999
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of mometasone furoate for treating upper airway passage diseases
    Patent number: 5837699
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: November 17, 1998
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of GM-CSF as a vaccine adjuvant
    Patent number: 5679356
    Abstract: The present invention is a method for enhancing the immune response of a mammal to a vaccine by administering to such a mammal an effective amount of GM-CSF in conjunction with a vaccine. The present invention further provides for pharmaceutical compositions containing an effective amount of GM-CSF and a vaccine. Kits containing GM-CSF and a vaccine are also disclosed.
    Type: Grant
    Filed: January 5, 1995
    Date of Patent: October 21, 1997
    Assignee: Schering Corporation
    Inventors: Eric M. Bonnem, Imtiaz A. Chaudry, Elliot Stupak
  • Non-chlorofluorocarbon aerosol formulations
    Patent number: 5474759
    Abstract: Aerosol formulations substantially free of chlorofluorocarbons for oral and/or nasal administration are described. The formulations comprise 1,1,1,2,3,3,3-heptafluoropropane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment utilizing the formulations are also described.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: December 12, 1995
    Assignee: Schering Corporation
    Inventors: Julianne Fassberg, Joel A. Sequeira, Imtiaz A. Chaudry, Michael Kopcha
  • Sustained release oral suspensions
    Patent number: 5186930
    Abstract: Stable sustained release wax- and polymer-coated drug-ion exchange resin complexes especially useful in preparing oral suspensions are disclosed.
    Type: Grant
    Filed: December 19, 1990
    Date of Patent: February 16, 1993
    Assignee: Schering Corporation
    Inventors: Patricia W. Kogan, Edward M. Rudnic, Joel A. Sequeira, Imtiaz A. Chaudry
  • Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine
    Patent number: 5100675
    Abstract: Pharmaceutical compositions for use in the treatment of cough/cold symptoms comprising loratadine, ibuprofen and pseudoephedrine are disclosed.
    Type: Grant
    Filed: November 13, 1990
    Date of Patent: March 31, 1992
    Assignee: Schering Corporation
    Inventors: Wing-Kee P. Cho, Winston A. Vadino, Imtiaz A. Chaudry
  • Sustained release oral suspensions
    Patent number: 4999189
    Abstract: Stable sustained release wax- and polymer-coated drug-ion exchange resin complexes especially useful in preparing oral suspensions are disclosed.
    Type: Grant
    Filed: November 14, 1988
    Date of Patent: March 12, 1991
    Assignee: Schering Corporation
    Inventors: Patricia W. Kogan, Edward M. Rudnic, Joel A. Sequeira, Imtiaz A. Chaudry